Comparative efficacy of once?a?day extended?release methylphenidate, two?times?daily immediate?release methylphenidate, and placebo in a laboratory school setting
Authors:
- 1 July 2004
- journal article
- clinical trial
- Published by Springer Nature in European Child & Adolescent Psychiatry
- Vol. 13 (1) , i93-i101
Abstract
Given the dosing limitations of methylphenidate short–acting preparations in treating ADHD, galenics with longer release of the substance were developed mainly to avoid drug intake during school hours.Keywords
This publication has 23 references indexed in Scilit:
- Pharmacokinetics of SLI381 (ADDERALL XR), an Extended-Release Formulation of AdderallJournal of the American Academy of Child & Adolescent Psychiatry, 2003
- Development of a New Once-a-Day Formulation of Methylphenidate for the Treatment of Attention-deficit/Hyperactivity DisorderArchives of General Psychiatry, 2003
- [Evidence based therapy of children and adolescents with attention deficit/hyperactivity hyperkinetic syndrome (ADHS)].2002
- A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of SLI381 (Adderall XR) in Children With Attention-Deficit/Hyperactivity DisorderPediatrics, 2002
- Extended-Release Methylphenidate (Ritalin?? LA*)Drugs, 2002
- Randomized, Controlled Trial of OROS Methylphenidate Once a Day in Children With Attention-Deficit/Hyperactivity DisorderPediatrics, 2001
- The Treatment of Attention-Deficit Hyperactivity Disorder: An Annotated Bibliography and Critical Appraisal of Published Systematic Reviews and MetaanalysesThe Canadian Journal of Psychiatry, 1999
- Empirically supported psychosocial treatments for attention deficit hyperactivity disorderJournal of Clinical Child Psychology, 1998
- Sustained Release Methylphenidate: Pharmacokinetic Studies in ADDH MalesJournal of the American Academy of Child & Adolescent Psychiatry, 1989
- Plasma levels of d-amphetamine in hyperactive childrenPsychopharmacology, 1979